Skip to main content

Table 1 Patients’ characteristics and treatment modalities

From: Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer – a long-term observation

Variable
Age Median (range) 57.0 (34.3–79.9)
Body mass index (BMI) Median (range) t0 a 25.0 (18.7–63.5)
Median (range) t1 a 25.5 (16.4–65.3)
pT stage   Number of patients (%)
 I 97 (48.5%)
 II 95 (47.5%)
 III 4 (2.0%)
 IV 3 (1.5%)
pN stage
  1 165 (82.5%)
2 28 (14.0%)
3 7 (3.5%)
Grading
  1 13 (6.5%)
2 144 (57.0%)
3 69 (34.5%)
Tumor size (mm) Median (range) 19 (0–90)
Resection volume (g) Median (range) 50 (5–931)
Resected lymph nodes (n) Median (range) 17.5 (2–55)
Involved lymph nodes (n) Median (range) 2 (0–22)
Hormone therapy   Number of patients (%)
Yes 152 (76.0%)
No 43 (21.5%)
Chemotherapy Total
yes 156 (78.0%)
no 44 (22.0%)
Adjuvant
Yes 133 (66.5%)
No 67 (33.5%)
Neoadjuvant
Yes 23 (11.5%)
No 177 (88.5%)
Radiation volume Breast
yes 200 (100%)
SCRT
Yes 75 (37.5%)
No 125 (62.5%)
Boost (breast)
Yes 65 (32.5%)
No 135 (67.5%)
Follow up (years) Median (range) 10.1 (4.9–15.9)
  1. at0 = at time of irradiation; t1 = at time of survey